ArticleInflammation2025
Zmiz1-Mediated SUMOylation of NLRP3 Inflammasome Regulates Satellite Glial Cell Activation and Neuronal Autophagy in Trigeminal Neuralgia.
Article in Inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Natural Neurobiological Active Compounds in Parkinson's Disease: Molecular Targets, Signaling Pathways, and Therapeutic Prospects.International journal of molecular sciences · 2026Pooled it
- Molecular mechanisms of NLRP3 inflammasome activation.Experimental & molecular medicine · 2026Review
- Genetic factors and comorbid pathologies interact to drive regional mitophagy alterations in Lewy body dementia.Acta neuropathologica · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Trigeminal neuralgia (TN) is characterized by neuroinflammation and satellite glial cell (SGC) activation, but the molecular mechanisms remain unclear. This study identifies zinc finger MIZ-type containing 1 (Zmiz1) as a key regulator that promotes SUMOylation of NLRP3 inflammasome, thereby influencing SGC activation and neuronal autophagy in TN. Using bioinformatics analysis, we identified Zmiz1 as a key SUMOylation-related gene involved in TN. Single-cell transcriptomics and co-expression network analysis revealed Zmiz1 enrichment in SGCs and neurons. Co-immunoprecipitation (Co-IP) and western blotting confirmed Zmiz1's interaction with NLRP3 and its role in promoting NLRP3 SUMOylation. In vitro experiments assessed the impact of Zmiz1 overexpression and knockdown on SGC activation, inflammatory cytokine secretion, and neuronal autophagy. A TN rat model was established to evaluate pain behavior, neuroinflammation, and neuronal apoptosis. Zmiz1 overexpression significantly enhanced NLRP3 SUMOylation, promoting SGC activation and inflammation while inhibiting neuronal autophagy. Conversely, silencing Zmiz1 reduced neuroinflammation and improved neuronal viability. In vivo, Zmiz1 knockdown alleviated TN-associated pain hypersensitivity and neuronal apoptosis. This study unveils a novel mechanism by which Zmiz1 regulates TN via NLRP3 SUMOylation, highlighting the Zmiz1/NLRP3 axis as a potential therapeutic target for TN treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.